DrDayanne Mozaner Bordin

Developing innovative mass spectrometry-based techniques for characterising small biomolecules, trace elements, proteomic bioindicators, and emerging nanomaterials in a forensic, biological, and clinical context.
Advancing the detection and diagnosis of cancer and metabolic diseases associated with chronic inflammation by implementing innovative techniques and technologies to provide patients with earlier and more accurate diagnoses, ultimately leading to improved health outcomes.